Future accountants should be as proficient in performing variance analyses and using data visualization software as they are with general ledgers.

Journey Medical's future hinges on Emrosi, a new formulation of minocycline for rosacea, showing superior efficacy. Read why I rate DERM stock a Buy.

One of the biggest challenges firms face when starting is how to stand out. For Byrd + Link, the winners of the Small Firm of the Year Award (Midlands, ...

UiPath's share price may have dropped since IPO, but it remains a key AI winner for 2025 with high growth potential and a ...